Naoyuki Nogami
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Denis Moro‐SibilotFrancesco OrlandiFabrice BarlésiFederico CappuzzoDelvys Rodríguez‐AbreuAnthony LeeRobert M. JotteDaniil Stroyakovskiy
- Topics
- Lung Cancer Treatments and Mutations (107 papers)Lung Cancer Research Studies (54 papers)Lung Cancer Diagnosis and Treatment (49 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Naoyuki Nogami
141 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 5.9k
- Pulmonary and Respiratory Medicine 5.4k
- Molecular Biology 1.4k
- Cancer Research 969
- Immunology 757
Countries citing papers authored by Naoyuki Nogami
This map shows the geographic impact of Naoyuki Nogami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyuki Nogami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyuki Nogami more than expected).
Fields of papers citing papers by Naoyuki Nogami
This network shows the impact of papers produced by Naoyuki Nogami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyuki Nogami. The network helps show where Naoyuki Nogami may publish in the future.
Co-authorship network of co-authors of Naoyuki Nogami
This figure shows the co-authorship network connecting the top 25 collaborators of Naoyuki Nogami. A scholar is included among the top collaborators of Naoyuki Nogami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoyuki Nogami. Naoyuki Nogami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 17 | |
| 5 | 40 | |
| 6 | 12 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | Safety/Tolerability of 1L Pembrolizumab+Chemotherapy in Japanese Patients with Metastatic Nonsquamous NSCLC: KEYNOTE-189 | 0 |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 32 | |
| 13 | 123 | |
| 14 | 2 | |
| 15 | 51 | |
| 16 | 11 | |
| 17 | 53 | |
| 18 | Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer. | 6 |
| 19 | 18 | |
| 20 | 3 |
About Naoyuki Nogami
Naoyuki Nogami is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 149 papers that have together received 7.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (107 papers), Lung Cancer Research Studies (54 papers) and Lung Cancer Diagnosis and Treatment (49 papers). The work is most often cited by research in Oncology (5.9k citations), Pulmonary and Respiratory Medicine (5.4k citations) and Cancer Research (969 citations). Naoyuki Nogami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Denis Moro‐Sibilot, Francesco Orlandi, Fabrice Barlési, Federico Cappuzzo, Delvys Rodríguez‐Abreu, Anthony Lee, Robert M. Jotte, Daniil Stroyakovskiy, Christian A. Thomas and Martin Reck. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.